07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Abstract</strong>: It is well established that morphine acts at κ-opioid receptors in the brain and spinal<br />

cord to produce analgesia, but the biochemical cascade following receptor activation remains<br />

unclear. Recently, a new cimetidine derivative named CC12 was reported to inhibit morphine<br />

antinociception by an action independent of opioid receptors (Hough et al., 2007). Because CC12<br />

has been found to have potent cytochrome P450- (CYP-) inhibitory activity (Stadel et al., 2008),<br />

the effects of several CYP and epoxygenase inhibitors were presently studied on morphine<br />

antinociception in rats. Nociceptive thresholds were assessed with the hot-plate and tail-flick<br />

tests. Intracerebroventricular (i.c.v.) administration of morphine (20 κg) produced significant<br />

increases in both tail-flick and hot-plate latencies, effects which were nearly completely<br />

abolished by pretreatment with a very low dose (10 nmol i.c.v.) of the CYP inhibitor miconazole.<br />

However, miconazole had activity at κ, δ, and θ- opioid, as well as histamine H3 receptors (Ki =<br />

0.6 - 4.5 µM ). A new CC12 derivative, MW-06-25 (N-((4-iodobenzyl) thiomethyl)-imidazole),<br />

was a potent CYP inhibitor in vitro (CYP2C19, IC50 = 19.1 nM), and blocked morphine<br />

antinociception in vivo (10 nmol; i.c.v.). MW-06-25 (10 µM) also lacked activity at arachidonate<br />

cyclooxygenase, 12-lipoxygenase, opioid receptors and H3 receptors. Furthermore, pretreatment<br />

with the epoxygenase inhibitor MS-PPOH (a non-imidazole, fatty-acid derivative, 30 and 300<br />

nmol; i.c.v.) resulted in significant, dose-dependent inhibition of morphine antinociception.<br />

These findings suggest a role <strong>for</strong> the PLA2/ arachidonic acid/ epoxygenase pathway in κ-opioid<br />

mediated morphine antinociceptive signaling. Elucidation of morphine‟s downstream mediators<br />

will enhance understanding of the biochemistry of analgesic circuits.<br />

Disclosures: J.L. Conroy, None; J. Nalwalk , None; M.A. VanAlstine, None; B.I. Knapp,<br />

None; J.M. Bidlack, None; O.P. Zuiderveld, None; R. Leurs, None; Z. Shan, None; S. Zhang,<br />

None; M.P. Wentland, None; L.B. Hough, None.<br />

Poster<br />

270. Pain: Opioids and Other Analgesics II<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 270.18/HH17<br />

Topic: D.08.r. Opioids and other analgesics<br />

Support: Department of Anesthesiology<br />

HL40881<br />

HL57120<br />

HL65272

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!